Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 2800 participants.
Also called NCT02093845
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,800 participants
- Registry
-
NCT02093845
-
- Other papers using this trial's data
- Everolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention: A Randomized Noninferiority Trial With 1-Year Follow-Up (SORT OUT VIII Trial)
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Unknown status
Technical summary
Registry record NCT02093845. Randomized; no masking; primary purpose treatment. Start 2014-02-10 (actual); primary completion 2015-08-24 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII
- Acronym
- SORT-OUT VIII
- Condition
- Coronary Artery Disease
- Condition
- Ischemic Heart Disease
- Intervention (Device)
- Biomatrix NeoFlex coronary stent
- Intervention (Device)
- SYNERGY stent
- Lead sponsor
- Aarhus University Hospital Skejby
- Collaborator
- Boston Scientific Corporation
- Collaborator
- Biosensors Europe SA
Record details
- Record id
cardio:ct-nct02093845- Content hash
a3412306ab4c9d62984c332bbc41e2f69108a266621d07f8442773d690b29b9c